Neuspera Medical focuses on innovative solutions for patients suffering from Urinary Urgency Incontinence (UUI), a common symptom of Overactive Bladder (OAB). The company has developed a modern, minimally invasive device that aims to enhance bladder control through its Implantable Sacral Neuromodulation (SNM) System. This system features an ultra-miniaturized implant that is designed to be less invasive than traditional options, providing a more comfortable experience for patients. The device works in conjunction with an external, wearable wireless transmitter, which utilizes Neuspera's proprietary Mid-Field Powering technology to deliver targeted stimulation to the nerves responsible for bladder function.

At the heart of Neuspera's technology is the ability to efficiently focus power to the implant using the body's natural composition, allowing for a streamlined and effective treatment approach. This innovative method not only enhances the efficacy of the therapy but also opens up possibilities for treating a range of conditions beyond UUI. By prioritizing a patient-first approach, Neuspera Medical is committed to improving the quality of life for individuals facing chronic health challenges through advanced bioelectronic medicine.

United States

Neuspera Medical, Inc. is committed to developing implantable medical device technology that will improve the lives of patients battling chronic illness. With the first intended indication for use as Urinary Urgency Incontinence (UUI), the platform technology is ultimately designed to deliver targeted bioelectronic medicine for a variety of conditions. Neuspera's minimally-invasive implants with external wearable transmitters offer the possibility for therapies to reach deeper, harder to access anatomical locations in the body.

Urogenital Diseases

51 daggett dr, san jose, california, united states, 95134-2109

Neuspera Medical

Neuspera Medical

Company Details